Impaired fecal elastase excretion in uremic pancreopathy.
To evaluate pancreatic exocrine function in uremia, 25 patients undergoing regular hemodialysis without clinical evidence of pancreatic disease and 25 healthy control subjects were studied by fecal elastase 1 and chymotrypsin. Abdominal ultrasonography and measurement of serum lipase, calcium, phosphate, and parathormone were also carried out. Fecal elastase was significantly lower (P < 0.001) in patients than in controls. Abnormally low values were found in 12/25 patients of whom six had values <100 microg/g. Fecal chymotrypsin was significantly lower (P < 0.05) in patients than in controls, with lower than normal values found in 10/25 patients. Fecal elastase was not related to the serum calcium, phosphate, or parathormone levels or to the period of dialysis. In patients serum lipase was normal or slightly elevated (<300 units/liter), and there was no evidence of pancreatic disease at ultrasound examination. The results lend further support to the existence of pancreatic function impairment in a significant number of patients with renal failure despite the absence of clinical and morphological evidence of pancreatic disease.
Ventrucci
M
M
Department of Internal Medicine and Gastroenterology, University of Bologna, Italy.
Cipolla
A
A
Middonno
M
M
Racchini
C
C
Simoni
P
P
Afandi
K
K
Grammatico
F
F
Campieri
C
C
D000368:Aged; D000369:Aged, 80 and over; D002918:Chymotrypsin / Q000032:analysis; D005243:Feces / Q000737:chemistry*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010196:Pancreatic Elastase / Q000032:analysis*; D010186:Pancreatic Function Tests; D010195:Pancreatitis / Q000175:diagnosis*; D012016:Reference Values; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications* / Q000175:diagnosis
D002918:Chymotrypsin; D010196:Pancreatic Elastase